Myeloid Leukemia, Chronic
Information
- Disease name
- Myeloid Leukemia, Chronic
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02890784 | Completed | Phase 3 | Dasatinib Holiday for Improved Tolerability | August 2016 | March 31, 2023 |
| NCT00478985 | Completed | N/A | Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia | June 2007 | December 2011 |
| NCT00481247 | Completed | Phase 3 | A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia | September 2007 | December 2015 |
| NCT00482703 | Completed | Phase 1/Phase 2 | A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia | May 2007 | May 2009 |
| NCT01660607 | Completed | Phase 1/Phase 2 | Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell | December 2011 | December 20, 2023 |
| NCT02222272 | Completed | Effect of 2nd Gen TKI in CML | January 1, 2010 | September 29, 2017 | |
| NCT00210119 | Terminated | Phase 2 | Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response | July 12, 2006 | March 2009 |
| NCT02543749 | Terminated | Phase 1/Phase 2 | DC Vaccination in CML | July 2014 | July 2022 |
| NCT02086487 | Terminated | Phase 4 | Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy | March 2013 | August 2016 |
| NCT00114959 | Terminated | Phase 2 | Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) | October 2005 | March 2009 |
| NCT00445822 | Unknown status | Registration of Children With CML and Treatment With Imatinib | March 2007 | December 2012 |